Weill Cornell Medicine finds a combination therapy lacking many debilitating effects manages mantle cell lymphoma, shrinking the malignancy and inducing remissions in most patients.
High levels of vitamin C kill certain kinds of colorectal cancers in cell cultures and mice, according to a new study from Weill Cornell Medicine investigators.
Weill Cornell Medicine researchers have found a new therapeutic approach to an aggressive form of lymphoma that may greatly increase the efficacy of treatment and result in better patient outcomes.
Investigators at Weill Cornell Medicine have discovered precisely how certain types of cancers spread to particular organs in the body, supporting the century-old "seed and soil" theory of metastasis.
Provost Michael Kotlikoff has called for proposals for feasibility and planning grants for academic programs that span the Ithaca and Cornell Tech campuses. The deadline to submit proposals is Jan. 22, 2016.
New insights into a complex mechanism that contributes to the growth of telomeres, the repetitive sequences of DNA that protect the end of a cell’s chromosomes, may lead to future cancer treatments.
Cornell researchers have engineered a tissue culture that mimics the complex environment of lymphomas – a technology that promises to rapidly advance our understanding and treatment of these tumors.
A new Weill Cornell Medicine analysis finds a much higher prevalence of hepatitis C than was previously estimated because some marginalized populations have been excluded from previous data.
In a new book, a Weill Cornell Medicine physician argues for advocacy and awareness on behalf of people with severe brain injuries who risk becoming deeply marginalized.
